Abstract
DNA vaccines have been on the scientific horizon since 1992, yet the past decade of clinical study has been precarious, with most trials exhibiting excellent safety, yet poor immune responses in humans. Despite the initial disappointments of immunogenicity observed in early clinical trials, the advantageous properties of plasmid DNA as a vaccine strategy over existing technologies continued to drive the field forward. Recently, non- human primate preclinical models as well as data generated in a few clinical trials have suggested that there are significant improvements in immunogenicity by the renewed enhanced DNA platform. This is due to a host of new technological improvements that together have improved vaccine antigen expression, delivery, and formulation resulting in improved immune potency. Improvements in plasmid delivery by modalities including the gene gun, biojector and most recently electroporation (EP) in particular, in combination with other technological developments such as species-specific codon optimization, improved RNA structural design, incorporation of novel leader sequences, novel formulations and adjuvant strategies have had a significant effect on immune outcome in relevant primate models and now humans. This new generation of DNA vaccines will likely have a more prominent role in vaccine clinical research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdulhaqq SA, Weiner DB (2008) DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 42(1–3):219–232
Agadjanyan MG, Kim JJ, Trivedi N, Wilson DM, Monzavi-Karbassi B, Morrison LD, Nottingham LK, Dentchev T, Tsai A, Dang K, Chalian AA, Maldonado MA, Williams WV, Weiner DB (1999) CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. J Immunol (Baltimore, MD: 1950) 162(6):3417–3427
Barouch DH, O’Brien KL, Simmons NL, King SL, Abbink P, Maxfield LF, Sun Y-H, La Porte A, Riggs AM, Lynch DM, Clark SL, Backus K, Perry JR, Seaman MS, Carville A, Mansfield KG, Szinger JJ, Fischer W, Muldoon M, Korber B (2010) Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat Med 16(3):319–323
Belshe R, Clements M, Dolin R (1993) Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. J Infect Dis 168:1387–1395
Benvenisty N, Reshef L (1986) Direct introduction of genes into rats and expression of the genes. Proc Natl Acad Sci USA 83(24):9551
Boyer J, Robinson T, Kutzler M (2005) SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques. J Med Primatol 34(5–6):262–270
Broderick KE, Shen X, Soderholm J, Lin F, McCoy J, Khan AS, Yan J, Morrow MP, Patel A, Kobinger GP, Kemmerrer S, Weiner DB, Sardesai NY (2011) Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Ther 18(3):258–265
Broderick K, Kardos T, McCoy J, Fons M (2011) Piezoelectric permeabilization of mammalian dermal tissue for in vivo DNA delivery leads to enhanced protein expression and increased immunogenicity. Hum Vaccines 7:22–28
Chiarella P, Massi E, De Robertis M, Sibilio A, Parrella P, Fazio VM, Signori E (2008) Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther 8(11):1645–1657
Chu Y, Xia M, Lin Y, Li A, Wang Y, Liu R, Xiong S (2006) Th2-dominated antitumor immunity induced by DNA immunization with the genes coding for a basal core peptide PDTRP and GM-CSF. Cancer Gene Ther 13(5):510–519
Coster HG (1965) A quantitative analysis of the voltage-current relationships of fixed charge membranes and the associated property of “punch-through”. Biophys J 5(5):669–686
Dubensky T, Campbell B (1984) Direct transfection of viral and plasmid DNA into the liver or spleen of mice. Proc Natl Acad Sci USA 81(23):7529–7533
Edelstein ML, Abedi MR, Wixon J (2007) Gene therapy clinical trials worldwide to 2007 – an update. J Gene Med 9(10):833–842
Elmowalid GA, Qiao M, Jeong SH, Borg BB, Baumert TF, Sapp RK, Hu Z, Murthy K, Liang TJ (2007) Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. Proc Natl Acad Sci USA 104(20):8427–8432
Fauci AS (2006) Pandemic influenza threat and preparedness. Emerg Infect Dis 12(1):73–77
Ferraro B, Morrow MP, Hutnick NA, Shin TH, Lucke CE, Weiner DB (2011) Clinical applications of DNA vaccines: current progress. Clin Infect Dis 53(3):296–302
Fu T, Ulmer J, Caulfield M, Deck R, Friedman A, Wang S, Liu X, Donnelly J, Liu M (1997) Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 3(6):362
Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90(24):11478–11482
Gagnon J, Ramanathan S, Leblanc C, Cloutier A, McDonald PP, Ilangumaran S (2008) IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T lymphocytes. J Immunol 180(12):7958–7968
Grønevik E, Tollefsen S, Sikkeland LIB, Haug T, Tjelle TE, Mathiesen I (2003) DNA transfection of mononuclear cells in muscle tissue. J Gene Med 5(10):909–917
Halwani R, Boyer JD, Yassine-Diab B, Haddad EK, Robinson TM, Kumar S, Parkinson R, Wu L, Sidhu MK, Phillipson-Weiner R, Pavlakis GN, Felber BK, Lewis MG, Shen A, Siliciano RF, Weiner DB, Sekaly RP (2008) Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques. J Immunol 180(12):7969–7979
Hirao LA, Wu L, Khan AS, Hokey DA, Yan J, Dai A, Betts MR, Draghia-Akli R, Weiner DB (2008) Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Vaccine 26(25):3112–3120
Iwasaki A, Stiernholm BJ, Chan AK, Berinstein NL, Barber BH (1997) Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 158(10):4591–4601
Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon MA, Dang K, Wang B, Boyer JD, Weiner DB (1997) In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol 158(2):816–826
Kim J, Yang J, Montaner L, Lee D (2000a) Coimmunization with IFN-gamma or IL-2, but not IL-13 or IL-4 cDNA can enhance Th1-type DNA vaccine-induced immune responses in vivo. J Interferon Cytokine Res 20(3):311–319
Kim JJ, Yang JS, VanCott TC, Lee DJ, Manson KH, Wyand MS, Boyer JD, Ugen KE, Weiner DB (2000b) Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants. J Virol 74(7):3427–3429
Ko HJ, Ko SY, Kim YJ, Lee EG, Cho SN, Kang CY (2005) Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B. Infect Immun 73(9):5666–5674
Kraynyak KA, Kutzler MA, Cisper NJ, Khan AS, Draghia-Akli R, Sardesal NY, Lewis MG, Yan J, Weiner DB (2010) Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques. Vaccine 28(8):1942–1951
Kutzler MA, Kraynyak KA, Nagle SJ, Parkinson RM, Zharikova D, Chattergoon M, Maguire H, Muthumani K, Ugen K, Weiner DB (2010) Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo. Gene Ther 17(1):72–82
Nagata T, Uchijima M, Yoshida A, Kawashima M, Koide Y (1999) Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms. Biochem Biophys Res Commun 261(2):445–451
Li S, Qi X, Gao Y, Hao Y, Cui L, Ruan L, He W (2010) IL-15 increases the frequency of effector memory CD8+ T cells in rhesus monkeys immunized with HIV vaccine. Cell Mol Immunol 7(6):491–494
Lin F, Shen X, McCoy JR, Mendoza JM, Yan J, Kemmerrer SV, Khan AS, Weiner DB, Broderick KE, Sardesai NY (2011) A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Vaccine
Long ZY, Niu PY, Gong ZY, Duan YY, Chen YW, Wang J, Tan H, Yuan J, Wu TC (2005) Role of heat shock protein 70 expression in DNA damage induced by 7, 8-dihydrodiol-9, 10-epoxide-benzo(a)pyrene. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 23(6):454–456
Luckay A, Sidhu MK, Kjeken R, Megati S, Chong SY, Roopchand V, Garcia-Hand D, Abdullah R, Braun R, Montefiori DC, Rosati M, Felber BK, Pavlakis GN, Mathiesen I, Israel ZR, Eldridge JH, Egan MA (2007) Effect of plasmid DNA vaccine design and In vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 81(10):5257–5269
MacGregor RR, Boyer JD, Ugen KE, Lacy KE, Gluckman SJ, Bagarazzi ML, Chattergoon MA, Baine Y, Higgins TJ, Ciccarelli RB, Coney LR, Ginsberg RS, Weiner DB (1998) First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 178(1):92–100
Maue AC, Waters WR, Palmer MV, Whipple DL, Minion FC, Brown WC, Estes DM (2004) CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis. Vaccine 23(6):769–779
Morris JC, Janik JE, White JD, Fleisher TA, Brown M, Tsudo M, Goldman CK, Bryant B, Petrus M, Top L, Lee CC, Gao W, Waldmann TA (2006) Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proc Natl Acad Sci USA 103(2):401–406
Neumann E, Kakorin S (1999) Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg 48(1):3–16
Neumann E, Schaefer-Ridder M, Wang Y (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1(7):841–845
Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9(24):1647–1652
Offit P (2005) The cutter incident: how America’s first polio vaccine led to the growing vaccine crisis. Yale University Press, New Haven
Okada E, Sasaki S, Ishii N, Aoki I, Yasuda T, Nishioka K, Fukushima J, Miyazaki J, Wahren B, Okuda K (1997) Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 159(7):3638–3647
Okino M, Mohri H (1987) Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res (Gann) 78(12):1319
Pasquini S, Xiang Z, Wang Y, He Z, Deng H, Blaszczyk-Thurin M, Ertl HC (1997) Cytokines and costimulatory molecules as genetic adjuvants. Immunol Cell Biol 75(4):397–401
Perera LP, Waldmann TA, Mosca JD, Baldwin N, Berzofsky JA, Oh SK (2007) Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice. J Virol 81(16):8774–8783
Ramanathan S, Dubois S, Chen XL, Leblanc C, Ohashi PS, Ilangumaran S (2011) Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes. J Immunol 186(9):5131–5141
Raz E, Watanabe A, Baird SM, Eisenberg RA, Parr TB, Lotz M, Kipps TJ, Carson DA (1993) Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci U S A 90(10):4523–4527
Rocha EPC (2004) Codon usage bias from tRNA’s point of view: redundancy, specialization, and efficient decoding for translation optimization. Genome Res 14(11):2279–2286
Ruprecht R (1999) Live attenuated AIDS viruses as vaccines: promise or peril? Immunol Rev 170:135–149
Santra S, Korber BT, Muldoon M, Barouch DH, Nabel GJ, Gao F, Hahn BH, Haynes BF, Letvin NL (2008) A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys. Proc Natl Acad Sci USA 105(30):10489–10494
Tang D, DeVit M (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356(6365):152–154
Thomas P (2001) Big shot: passion, politics, and the struggle for an AIDS vaccine. PublicAffairs, New York, p 515
Tsuji T, Hamajima K, Ishii N, Aoki I (1997) Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the virel antigen. Eur J Immunol 27(3):782–787
Ulmer J, Donnelly J, Parker S, Rhodes G (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (New York)
Valentin A, Lu W, Rosati M, Schneider R, Albert J, Karlsson A, Pavlakis GN (1998) Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc Natl Acad Sci USA 95(15):8886–8891
Wang B, Ugen K, Srikantan V (1993) Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90(9):4156–4160
Weiner DB, Kutzler MA, Kraynyak KA, Sylvester AJ, Ginsberg AA, Carnathan D, Kathuria N, Khan AS, Pahar B, Moldoveanu Z, Mestecky J, Betts MR, Marx P, Weiner DB (2011) Co-delivery of mucosal chemokine plasmids in a systemically administered DNA vaccine elicits systemic and mucosal immune responses in rhesus macaques. Oral presentation in: ICMI 2011. 15th International Congress of Mucosal Immunology. Paris, France 5–8.
Wolff J, Malone R, Williams P, Chong W (1990) Direct gene transfer into mouse muscle in vivo. Science (New York)
Xiang Z, Ertl HC (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2(2):129–135
Yewdell JW, Bennink JR (1999) Mechanisms of viral interference with MHC class I antigen processing and presentation. Annu Rev Cell Dev Biol 15:579–606
Yin J, Dai A, Kutzler MA, Shen A, Lecureux J, Lewis MG, Waldmann T, Weiner DB, Boyer JD (2008) Sustained suppression of SHIV89.6P replication in macaques by vaccine-induced CD8+ memory T cells. AIDS 22(14):1739–1748
Zhao J, Lai L, Amara RR, Montefiori DC, Villinger F, Chennareddi L, Wyatt LS, Moss B, Robinson HL (2009) Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia. J Virol 83(9):4102–4111
Zheng JP, Sun JY, Guo L, Liang HS, Tian FJ, Wu TC (2007) Relationship between heat shock protein 72 and DNA genetic damage in peripheral blood lymphocytes of coke oven workers. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 25(7):394–397
Acknowledgements
D.B.W. and the D.B.W. laboratory would like to note several commercial relationships for purposes of disclosure. These relations may include the provision of board or committee service, consultations, stock ownership, S.R.A., royalties, etc. on the part of one or both parties as a result of collaborative work with commercial entities including but not limited to Novartis, Inovio, VGXi, BMS, Medarex, Pfizer, Virxsys, Ichor, Merck, and Althea.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag/Wien
About this chapter
Cite this chapter
Ginsberg, A.A., Shen, X., Hutnick, N.A., Weiner, D.B. (2012). Improvement of DNA Vaccines by Electroporation. In: Thalhamer, J., Weiss, R., Scheiblhofer, S. (eds) Gene Vaccines. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0439-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0439-2_7
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0438-5
Online ISBN: 978-3-7091-0439-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)